中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
15期
39-41
,共3页
甲基强的松龙%多发性硬化病%临床效果
甲基彊的鬆龍%多髮性硬化病%臨床效果
갑기강적송룡%다발성경화병%림상효과
Methylprednisolone%Multiple sclerosis%Clinical effect
目的：探讨甲基强的松龙鞘内注射治疗多发性硬化病患者的临床效果。方法对我院接收治疗的40例多发性硬化病患者资料进行分析，将患者根据入院时间顺序随机分为两组。对照组采用红花、依达拉奉，甲钴胺同时配合中药治疗，实验组在对照组基础上联合甲基强的松龙鞘内注射治疗，比较两组治疗效果。结果实验组治疗总有效率为90%，与对照组相比，差异有统计学意义（65%）（P＜0.05）；实验组在我院治疗后对我院总体满意度较高，达到90%，高于对照组（P＜0.05）；实验组临床症状评分为（18.80±3.45）、神经功能体征评分为（9.11±2.40）、EDSS评分为（6.43±1.71），与对照组相比，差异有统计学意义（P＜0.05）；实验组治疗后在我院住院（2.6±0.4）d，短于对照组（P＜0.05）。结论红花、依达拉奉，甲钴胺同时配合中药治疗基础上采用甲基强的松龙鞘内注射治疗多发性硬化病效果显著，值得推广使用。
目的：探討甲基彊的鬆龍鞘內註射治療多髮性硬化病患者的臨床效果。方法對我院接收治療的40例多髮性硬化病患者資料進行分析，將患者根據入院時間順序隨機分為兩組。對照組採用紅花、依達拉奉，甲鈷胺同時配閤中藥治療，實驗組在對照組基礎上聯閤甲基彊的鬆龍鞘內註射治療，比較兩組治療效果。結果實驗組治療總有效率為90%，與對照組相比，差異有統計學意義（65%）（P＜0.05）；實驗組在我院治療後對我院總體滿意度較高，達到90%，高于對照組（P＜0.05）；實驗組臨床癥狀評分為（18.80±3.45）、神經功能體徵評分為（9.11±2.40）、EDSS評分為（6.43±1.71），與對照組相比，差異有統計學意義（P＜0.05）；實驗組治療後在我院住院（2.6±0.4）d，短于對照組（P＜0.05）。結論紅花、依達拉奉，甲鈷胺同時配閤中藥治療基礎上採用甲基彊的鬆龍鞘內註射治療多髮性硬化病效果顯著，值得推廣使用。
목적：탐토갑기강적송룡초내주사치료다발성경화병환자적림상효과。방법대아원접수치료적40례다발성경화병환자자료진행분석，장환자근거입원시간순서수궤분위량조。대조조채용홍화、의체랍봉，갑고알동시배합중약치료，실험조재대조조기출상연합갑기강적송룡초내주사치료，비교량조치료효과。결과실험조치료총유효솔위90%，여대조조상비，차이유통계학의의（65%）（P＜0.05）；실험조재아원치료후대아원총체만의도교고，체도90%，고우대조조（P＜0.05）；실험조림상증상평분위（18.80±3.45）、신경공능체정평분위（9.11±2.40）、EDSS평분위（6.43±1.71），여대조조상비，차이유통계학의의（P＜0.05）；실험조치료후재아원주원（2.6±0.4）d，단우대조조（P＜0.05）。결론홍화、의체랍봉，갑고알동시배합중약치료기출상채용갑기강적송룡초내주사치료다발성경화병효과현저，치득추엄사용。
Objective To investigate the clinical effect of intrathecal injection of methylprednisolone for the treatment of multiple sclerosis patients. Methods Our hospital receiving treatment of 40 cases of multiple sclerosis were analyzed,the patients were randomly divided into two groups of time.The control group using safflower,edaravone,mecobalamin and combined with traditional Chinese medicine therapy,the experimental group in the control group based on the combined with intrathecal injection of methylprednisolone treatment,treatment effects were compared between the two groups. Results In the experimental group, the total effective rate was 90%and the control group compared with the significant advantage(65%)(P<0.05);the experiment group were higher in our hospital overall satisfaction in our hospital after treatment,up to 90%higher than that of the control group(P<0.05);clinical symptoms in experimental group was(18.80±3.45),nerve function symptoms score(9.11±2.40), EDSS score(6.43±1.71) and compared with the control group,a significant advantage(P<0.05);the experiment group after treatment in our hospital(2.6±0.4) shorter than the control group(P < 0.05). Conclusion Edaravone and Mecobalamin,safflower,at the same time with Chinese medicine treatment based on the use of intrathecal injection of methylprednisolone for the treatment of multiple sclerosis disease effect,is worthy to be popularized.
